home / stock / apto / apto news


APTO News and Press, Aptose Biosciences Inc. From 05/16/19

Stock Information

Company Name: Aptose Biosciences Inc.
Stock Symbol: APTO
Market: NASDAQ
Website: aptose.com

Menu

APTO APTO Quote APTO Short APTO News APTO Articles APTO Message Board
Get APTO Alerts

News, Short Squeeze, Breakout and More Instantly...

APTO - Aptose to Present New Preclinical Data for CG-806 at the 24th Congress of The European Hematology Association

SAN DIEGO and TORONTO, May 16, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics targeting the underlying mechanisms of cancer, today annou...

APTO - VIDEO - Aptose Biosciences CEO: Clinical Programs in the Works

Play Video At the Bloom Burton & Co. Healthcare Investor Conference (BBHIC), the Investing News Network had the opportunity to catch up with William Rice, CEO of Aptose Biosciences (TSX: APS ,NASDAQ:APTO), to...

APTO - Aptose to Present at May Investor Conferences

SAN DIEGO and TORONTO, May 13, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO; TSX: APS), a clinical-stage biotechnology company developing first-in-class agents that target the dysregulated processes and signaling pathways of cancer cells and address unmet medical needs of ...

APTO - Aptose Announces Commencement of Previously Announced $20.0 Million Common Share Purchase Agreement with Aspire Capital Fund, LLC

SAN DIEGO and TORONTO, May 10, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the underlying mechanisms of cancer, today ann...

APTO - Aptose Biosciences Inc. (APTO) CEO William Rice on Q1 2019 Results - Earnings Call Transcript

Aptose Biosciences Inc. (APTO) Q1 2019 Earnings Conference Call May 7, 2019 17:00 ET Company Participants Susan Pietropaolo - SMP Communications William Rice - President & CEO Gregory Chow - SVP & CFO Conference Call Participants Gregory Renza - RBC Capital Markets ...

APTO - Aptose Biosciences beats by $0.03

Aptose Biosciences (NASDAQ: APTO ): Q1 GAAP EPS of -$0.14 beats by $0.03 . Press Release More news on: Aptose Biosciences Inc., Earnings news and commentary, Healthcare stocks news, ,

APTO - Aptose Reports Results for the First Quarter Ended March 31, 2019

─  Patient Dosed at Second Dose Level in APTO-253 Clinical Trial ─ ─  Patient Screening Initiated for CG-806 Clinical Trial ─ Conference Call and Webcast at 5pm EDT Today SAN DIEGO and TORONTO, May 07, 2019 (GLOBE NEWSWIRE) -- Aptose Biosc...

APTO - BBHIC 2019, Day 2: Notes From the Floor

Play Video After a successful first day to the Bloom Burton & Co. Healthcare Investor Conference (BBHIC), day two proved to be just as exciting for the annual event.  Brian Bloom, CEO of Bloom Burto...

APTO - Eyes On Apple, Uber, F8 And Avengers (Stocks To Watch Podcast)

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday (you c...

APTO - Stocks To Watch: Eyes On Apple, Uber, F8 And Avengers

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. The U.S. will send a high-level delegation to Beijing next week as trade negotiatio...

Previous 10 Next 10